$22M Award Won't Stop Cordis' Infringement, Fed. Circ. Told

Law360, Washington (October 1, 2012, 7:52 PM EDT) -- Spectralytics Inc. told a Federal Circuit panel on Monday that a $22 million verdict against Cordis Corp. and stent manufacturer Norman Noble Inc. won't deter the companies from infringing on smaller companies' patents, and urged the appellate judges to push the district court judge to add onto the penalties.

While U.S. District Judge Patrick Schiltz added $500,000 in enhanced damages to Spectralytics' initial $22 million award in December over the stent-cutting machine patent infringement, the company's counsel, Alan G. Carlson, said the amount was minuscule in...
To view the full article, register now.